Skip to main content

Peer Review reports

From: Reevaluation of adverse drug reactions of psychiatric drugs under the chinese drug volume-based procurement policy

Original Submission
22 Nov 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
22 Dec 2021 Reviewed Reviewer Report - Francisco Miguel Escandell-rico
29 Dec 2021 Reviewed Reviewer Report - Judit Riera-arnau
12 Jan 2022 Author responded Author comments - Haohao Zhu
Resubmission - Version 3
12 Jan 2022 Submitted Manuscript version 3
23 Jan 2022 Reviewed Reviewer Report - Francisco Miguel Escandell-rico
2 Feb 2022 Reviewed Reviewer Report - Judit Riera-arnau
23 Feb 2022 Author responded Author comments - Haohao Zhu
Resubmission - Version 4
23 Feb 2022 Submitted Manuscript version 4
24 Feb 2022 Author responded Author comments - Haohao Zhu
Resubmission - Version 5
24 Feb 2022 Submitted Manuscript version 5
17 Mar 2022 Reviewed Reviewer Report - Francisco Miguel Escandell-rico
21 Mar 2022 Reviewed Reviewer Report - Judit Riera-arnau
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
28 Mar 2022 Editorially accepted
31 Mar 2022 Article published 10.1186/s12913-022-07851-4

You can find further information about peer review here.

Back to article page